{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Central+Serous+Chorioretinopathy", "query": { "condition": "Chronic Central Serous Chorioretinopathy" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T20:26:37.130Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00211445", "title": "Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Central Serous Chorioretinopathy" ], "interventions": [ { "name": "Photodynamic Therapy with Verteporfin", "type": "PROCEDURE" }, { "name": "verteporfin", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Manhattan Eye, Ear & Throat Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2002-07", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2007-09-28", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00211445" }, { "nct_id": "NCT01990677", "title": "Eplerenone for the Treatment of Central Serous Chorioretinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Central Serous Chorioretinopathy" ], "interventions": [ { "name": "25mg Eplerenone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wills Eye", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2013-10", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2018-11-07", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 10, "location_summary": "Cherry Hill, New Jersey • Marlton, New Jersey • Mays Landing, New Jersey + 7 more", "locations": [ { "city": "Cherry Hill", "state": "New Jersey" }, { "city": "Marlton", "state": "New Jersey" }, { "city": "Mays Landing", "state": "New Jersey" }, { "city": "Bala-Cynwyd", "state": "Pennsylvania" }, { "city": "Bethlehem", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01990677" }, { "nct_id": "NCT01585441", "title": "Finasteride for Chronic Central Serous Chorioretinopathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Retinal Disease" ], "interventions": [ { "name": "Finasteride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2012-04", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2014-12-04", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01585441" }, { "nct_id": "NCT01880788", "title": "Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age Related Macular Degeneration", "Choroidal Neovascularization", "Central Serous Chorioretinopathy" ], "interventions": [], "intervention_types": [], "sponsor": "Sequenom, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 152, "start_date": "2012-11", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-09-18", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01880788" }, { "nct_id": "NCT00837252", "title": "Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Retinal Disease" ], "interventions": [ { "name": "Finasteride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2009-02", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2016-09-26", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00837252" }, { "nct_id": "NCT01227993", "title": "Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Retinal Disease" ], "interventions": [ { "name": "Finasteride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2010-10", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01227993" }, { "nct_id": "NCT00211393", "title": "A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Central Serous Chorioretinopathy" ], "interventions": [ { "name": "ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Manhattan Eye, Ear & Throat Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 5, "start_date": "2005-05", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2012-10-25", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00211393" }, { "nct_id": "NCT00489840", "title": "Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Central Serous Chorioretinopathy" ], "interventions": [ { "name": "Anecortave Acetate Sterile suspension 15 mg", "type": "DRUG" }, { "name": "Anecortave Acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Manhattan Eye, Ear & Throat Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2007-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-10-25", "last_synced_at": "2026-07-23T20:26:37.130Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00489840" } ] }